(Q41018564)

25 September 2017

Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice (English)

1 reference

25 September 2017

1 reference

1 reference

5

Catovsky D

1 reference

25 September 2017

Clutterbuck RD

1

1 reference

25 September 2017

Millar BC

2

1 reference

25 September 2017

Powles RL

3

1 reference

25 September 2017

Newman A

4

1 reference

25 September 2017

Jarman M

6

1 reference

25 September 2017

Millar JL

7

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

British Journal of Haematology

25 September 2017

1 reference

25 September 2017

102

1 reference

25 September 2017

522-527

1 reference

25 September 2017

2

1 reference

Cholesterol inhibition, cancer, and chemotherapy

25 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Effect of pravastatin, a potent 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on survival of AH130 hepatoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

HMG-CoA reductase inhibitors: role in normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

Ras genes and acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00783.X

10.1046/J.1365-2141.1998.00783.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference